These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 8155260)
1. Are we closer to selective immunotherapy for autoimmune diseases? Lamont A Immunol Today; 1994 Feb; 15(2):45-7. PubMed ID: 8155260 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies for the therapeutic induction of tolerance. Waldmann H; Qin S; Cobbold SP Immunol Ser; 1993; 59():85-99. PubMed ID: 8461402 [No Abstract] [Full Text] [Related]
3. [The trimolecular complex as a target for specific immunotherapy in experimental autoimmune encephalomyelitis--applications for multiple sclerosis and other human autoimmune disease]. Miller A; Weiner HL; Abramsky O Harefuah; 1992 Aug; 123(3-4):110-5. PubMed ID: 1516860 [No Abstract] [Full Text] [Related]
4. Therapeutic intervention in autoimmunity. Tisch R; Yang XD; McDevitt HO Behring Inst Mitt; 1994 Jul; (94):171-8. PubMed ID: 7998910 [No Abstract] [Full Text] [Related]
5. Immunospecific drug design--prospects for treatment of autoimmune diseases. Arnon R; Teitelbaum D Ther Immunol; 1994 Jan; 1(1):65-70. PubMed ID: 7584481 [TBL] [Abstract][Full Text] [Related]
6. [The T cell receptor abnormalities and autoimmune diseases]. Takeno M; Sakane T Tanpakushitsu Kakusan Koso; 1990 Apr; 35(5):865-73. PubMed ID: 2362962 [No Abstract] [Full Text] [Related]
7. Immunotherapy in autoimmune diseases. Miller A; Hafler DA; Weiner HL Curr Opin Immunol; 1991 Dec; 3(6):936-40. PubMed ID: 1793539 [TBL] [Abstract][Full Text] [Related]
8. Understanding multiple sclerosis: new immunologic insights and prospects for specific therapy. Ransohoff RM Compr Ther; 1991 Nov; 17(11):3-6. PubMed ID: 1799959 [No Abstract] [Full Text] [Related]
9. T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy. Noy R; Eppel M; Haus-Cohen M; Klechevsky E; Mekler O; Michaeli Y; Denkberg G; Reiter Y Expert Rev Anticancer Ther; 2005 Jun; 5(3):523-36. PubMed ID: 16250828 [TBL] [Abstract][Full Text] [Related]
10. Principles of autoimmune disease: pathogenesis, genetics and specific immunotherapy. Adams DD; Knight JG J Clin Lab Immunol; 2003; 52():1-22. PubMed ID: 15079886 [TBL] [Abstract][Full Text] [Related]
11. Immune therapy for autoimmune diseases. Steinman L Science; 2004 Jul; 305(5681):212-6. PubMed ID: 15247472 [TBL] [Abstract][Full Text] [Related]
12. Selective targets for immunotherapy in autoimmune disease. Yang XD; Tisch R; McDevitt HO Chem Immunol; 1995; 60():20-31. PubMed ID: 7857527 [No Abstract] [Full Text] [Related]
13. Killers come to the rescue. Wahren-Herlenius M; Kuchroo VK Nat Biotechnol; 2002 Dec; 20(12):1205-6. PubMed ID: 12454670 [No Abstract] [Full Text] [Related]
14. The fidelity, occasional promiscuity, and versatility of T cell receptor recognition. Godfrey DI; Rossjohn J; McCluskey J Immunity; 2008 Mar; 28(3):304-14. PubMed ID: 18342005 [TBL] [Abstract][Full Text] [Related]
15. Autoimmune disease: immunotherapy by peptides? Janeway CA Nature; 1989 Oct; 341(6242):482-3. PubMed ID: 2477706 [No Abstract] [Full Text] [Related]
16. [The current outlook in the therapy of autoimmune diseases]. Sebastiani GD; Passiu G Ann Ital Med Int; 1992; 7(2):95-101. PubMed ID: 1467130 [TBL] [Abstract][Full Text] [Related]
17. Anti-class II antibody treatment in autoimmune diseases. Boitard C Immunol Ser; 1993; 59():279-93. PubMed ID: 8461393 [No Abstract] [Full Text] [Related]
19. Neurological autoimmune disease and the trimolecular complex of T-lymphocytes. Hohlfeld R Ann Neurol; 1989 Jun; 25(6):531-8. PubMed ID: 2662895 [TBL] [Abstract][Full Text] [Related]
20. Lighting up TCR takes advantage of serial triggering. Chakraborty AK Nat Immunol; 2002 Oct; 3(10):895-6. PubMed ID: 12352963 [No Abstract] [Full Text] [Related] [Next] [New Search]